Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

FRACTYL HEALTH, INC. (GUTS) Cash Flow Statement

FRACTYL HEALTH, INC. (GUTS) generated -$82.4M of operating cash flow over the twelve months to 2026-06-30, spent $11000 on capital expenditure and had free cash flow of -$82.4M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

GUTSFRACTYL HEALTH, INC.Follow GUTS — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
14.3M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 17 days
LineFY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-65.5-90.3-82.4
Capital expenditure1.80.6-0.0
Free cash flow-67.3-90.9-82.4
Stock-based compensation14.46.7—

USD millions · SEC XBRL

FRACTYL HEALTH, INC. — questions

What is FRACTYL HEALTH, INC.'s operating cash flow?
-$82.4M over the twelve months to 2026-06-30.
How much does FRACTYL HEALTH, INC. spend on capital expenditure?
$11000 over the twelve months to 2026-06-30.
What is FRACTYL HEALTH, INC.'s free cash flow?
-$82.4M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from FRACTYL HEALTH, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.